MedPath

Computer Screen Properties Study

Not Applicable
Completed
Conditions
Dry Eye Syndromes
Registration Number
NCT05042960
Lead Sponsor
NYU Langone Health
Brief Summary

The purpose of this study is to identify how various popular methods of changing computer screen settings affect dry eye symptoms (eye pain, grittiness, tearing, burning, etc.). Specifically, this study will examine if there are differences in effects of blue light blocking (F.lux app or night shift) versus reducing screen brightness on the symptoms of dry eye.

Detailed Description

After the initial survey, participants will be randomized by a randomization tool internal to Redcap to be in one of three arms of intervention: no intervention, screen brightness reduction to 50%, and tone modulator application. Instructions will be e-mailed to participants to explain the steps they must take depending on which treatment arm they are randomized to. Adherence will be monitored and assessed at the time of post-intervention survey. If participants have issues with the software of complying, they will be able to contact the research team at any point.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
47
Inclusion Criteria
  • Adult person (18+) with intact vision who uses computers
Exclusion Criteria
  • Children (<18 years)
  • Adult person without intact vision
  • Adult who does not use computer screens

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The severity of dry eye symptomsDay 30

Participants will complete a post-intervention survey to measure the severity of dry eye symptoms.

The frequency of dry eye symptomsDay 30

Participants will complete a post-intervention survey to measure the frequency of dry eye symptoms.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

NYU Langone Health

🇺🇸

New York, New York, United States

NYU Langone Health
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.